Home Recalls D-1250-2020
Class II · Moderate risk Terminated Initiated Apr 20, 2020 (6 years ago)
Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.
What was recalled
Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03
Recalling firm Lupin Pharmaceuticals Inc.
NDC code 68180-0981-03
Origin MD, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-1250-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Jun 20, 2025
Reason Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets…
Class II · Moderate risk Terminated Nov 15, 2024
Reason Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.
Class III · Low risk Terminated Oct 27, 2023
Reason Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
Class II · Moderate risk Terminated Sep 15, 2022
Reason Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Class II · Moderate risk Terminated Sep 13, 2022
Reason Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.